PreprintAll rights reservedbioRxiv
Loss of Ferroptosis-suppressors Accelerates Breast Cancer Recurrence by Promoting Dormancy Exit
- 1University of Pennsylvania Perelman School of Medicine
Related
- ID4 enhances ferroptosis sensitivity in gastric cancer by promoting ubiquitination degradation of GPX4.
- Fatostatin targets SCAP/SREBP pathway to inhibit ARID1A-deficient non-small cell lung cancer by promoting ferroptosis
- [Mechanism of NUF2 in Promoting NSCLC Progression through the Regulation of Ferroptosis].
- WITHDRAWN: Heterozygous germline MSH3 mutations, and probably MLH3 mutations, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk
- A genetic screen for suppressors of neuron degeneration in a C. elegans sod-1G85R model of Amyotrophic Lateral Sclerosis
BibTeX
@misc{shea2026loss,
title = {{Loss of Ferroptosis-suppressors Accelerates Breast Cancer Recurrence by Promoting Dormancy Exit}},
author = {E. K. Shea and M. Lawrence-Paul and A. Sreekumar and B. Benz and C. Sterner and J. Wang and Y. Chen and T.-c. Pan and G. Belka and L. A. Chodosh},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.22.761187},
url = {https://www.biorxiv.org/content/10.64898/2026.10.22.761187v1},
}
RIS
TY - UNPB
TI - Loss of Ferroptosis-suppressors Accelerates Breast Cancer Recurrence by Promoting Dormancy Exit
AU - E. K. Shea
AU - M. Lawrence-Paul
AU - A. Sreekumar
AU - B. Benz
AU - C. Sterner
AU - J. Wang
AU - Y. Chen
AU - T.-c. Pan
AU - G. Belka
AU - L. A. Chodosh
PY - 2026
DA - 2026/10/22
PB - bioRxiv
DO - 10.64898/2026.10.22.761187
UR - https://www.biorxiv.org/content/10.64898/2026.10.22.761187v1
ER -